Systemic vascular and organ functions in transgender women receiving feminizing hormone therapy
Open Access
- 1 July 2026
- journal article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 141 (1) , 29-37
Abstract
The primary finding of the present study is that transgender women demonstrate similar macrovascular and microvascular function as well as renal and hepatic function to cisgender women. Regardless of marked differences in circulating sex hormone profiles, no evidence of vascular dysfunction or organ impairment was observed in transgender women. These findings suggest that prolonged exposure to an estrogen-dominant hormonal milieu is sufficient to induce a female-typical physiological phenotype across multiple organ systems.Keywords
Funding Information
- Chulalongkorn University
This publication has 35 references indexed in Scilit:
- Feminizing gender‐affirming hormone therapy for the transgender and gender diverse population: An overview of treatment modality, monitoring, and risksNeurourology and Urodynamics, 2022
- Sex and Gender Aspects in Vascular Ageing – Focus on Epidemiology, Pathophysiology, and OutcomesHeart, Lung and Circulation, 2021
- Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone TherapyThe Journal of Sexual Medicine, 2021
- Energy Expenditure and Macronutrient Oxidation in Response to an Individualized Nonshivering Cooling ProtocolObesity, 2020
- Influence of Sex on the Progression of Chronic Kidney DiseaseMayo Clinic Proceedings, 2019
- Estrogen: The necessary evil for human health, and ways to tame itBiomedicine & Pharmacotherapy, 2018
- Effects of Buddhist walking meditation on glycemic control and vascular function in patients with type 2 diabetesComplementary Therapies in Medicine, 2016
- Comparison of Gonadotropin-Releasing Hormone Agonists and OrchiectomyJAMA Oncology, 2016
- The Performance of the World Health Organization’s WHOQOL-BREF in Assessing the Quality of Life of Thai College StudentsSocial Indicators Research, 2008
- Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal womenAtherosclerosis, 2006